JAMES HULVEY: Open Payments
NPI 1982780060 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,812 in 114 payments from 18 companies in 2025. Trend: 2023 $880 · 2024 $1,352 · 2025 $1,812
Food & beverage: $1,784Education: $28
| Company | Payments | Amount |
|---|---|---|
| OPKO Pharmaceuticals, LLC | 35 | $311 |
| Calliditas Therapeutics US Inc. | 16 | $271 |
| Otsuka America Pharmaceutical, Inc. | 16 | $267 |
| Novo Nordisk Inc | 6 | $180 |
| Travere Therapeutics, Inc. | 9 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| SCPHARMACEUTICALS INC. | 4 | $84 |
| Amgen Inc. | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
Products named: RAYALDEE, TARPEYO, JYNARQUE, Ozempic, Kerendia, FUROSCIX, JARDIANCE, TAVNEOS.
Industry payments across TN — which companies pay providers there.
